Pretty pathetic. Aurinia has only 25% institutional ownership. Wonder why....
Orbimed Advisors LLC cut its holdings in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) by 73.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 167,419 shares of the biotechnology company’s stock after selling 458,856 shares during the period. Orbimed Advisors LLC owned about 0.20% of Aurinia Pharmaceuticals worth $943,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in the company. Stifel Financial Corp grew its stake in shares of Aurinia Pharmaceuticals by 98.4% during the first quarter. Stifel Financial Corp now owns 21,718 shares of the biotechnology company’s stock valued at $113,000 after acquiring an additional 10,772 shares in the last quarter. Cornerstone Wealth Management LLC acquired a new stake in shares of Aurinia Pharmaceuticals during the second quarter valued at about $2,000,000. Creative Planning grew its stake in shares of Aurinia Pharmaceuticals by 8.2% during the second quarter. Creative Planning now owns 171,200 shares of the biotechnology company’s stock valued at $964,000 after acquiring an additional 13,000 shares in the last quarter. DRW Securities LLC acquired a new stake in shares of Aurinia Pharmaceuticals during the first quarter valued at about $162,000. Finally, Ironwood Investment Management LLC grew its stake in shares of Aurinia Pharmaceuticals by 18.0% during the second quarter. Ironwood Investment Management LLC now owns 218,568 shares of the biotechnology company’s stock valued at $1,231,000 after acquiring an additional 33,279 shares in the last quarter. Institutional investors own 24.93% of the company’s stock.
